Skip to main content
Equibles

MetLife Investment Management, LLC

Position in EBS — Emergent BioSolutions Inc.

CIK 1529735 Whippany, NJ
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$250,838
+$41,371 QoQ
Shares Held
29,933
+18.6% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 194 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $106,800,407 across 37 Drug Manufacturers - Specialty & Generic names. EBS ranks #30 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALKS
Alkermes plc.
 512,924 $26,877,217
2 UTHR
UNITED THERAPEUTICS Corp
 20,421 $11,064,710
3 NBIX
Neurocrine Biosciences Inc
 51,732 $8,718,911
4 ZTS
Zoetis Inc.
 108,947 $7,828,931
5 HIMS
Hims & Hers Health, Inc.
 224,462 $7,782,097
6 LNTH
Lantheus Holdings, Inc.
 68,281 $7,575,094
7 ELAN
Elanco Animal Health Inc
 240,384 $5,915,850
8 VTRS
Viatris Inc
 266,382 $4,230,146

All Filings in EBS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $250,838 29,933
2026-03-31 $209,467 25,237
2025-12-31 $388,338 31,419
2025-09-30 $233,139 26,433
2025-06-30 $208,511 32,682
2024-06-30 $0 0
2023-12-31 $65,748 27,395
2023-09-30 $93,143 27,395
2023-06-30 $201,353 27,395
2023-03-31 $283,812 27,395
2022-12-31 $323,534 27,395
2022-09-30 $575,021 27,395
2022-06-30 $850,340 27,395
2022-03-31 $1,124,838 27,395
2021-12-31 $764,985 17,598
2021-09-30 $2,030,739 40,558
2021-06-30 $2,542,087 40,357
2021-03-31 $3,809,310 41,000
2020-12-31 $3,885,504 43,365
2020-09-30 $4,595,085 44,470
2020-06-30 $1,582,469 20,011
2020-03-31 $1,157,836 20,011